GeneSight
genesight.com
Actively hiring
Psychiatric Care
Precision Medicine
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
Wireframe Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Wireframe Ventures Similar startupsby what they do, their industry and backers
Overstory Health offers personalized IOP and PHP programs in Boston, including therapy and medication management, to support your mental…
Amaha provides evidence-based & person-centric mental health support across therapy, psychiatry, assessments, and inpatient care.
Velsera is a leading provider of omics analytics solutions, powering precision medicine and enhancing the healthcare and life sciences…
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
A novel priming approach that increases circulating tumor DNA—improving detection and enabling better clinical decisions without changing…
Passkey’s Locksmith platform uses AI to identify synergistic drug combinations from approved assets using human genetic data; enabling…
News
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
SALT LAKE CITY, April 30, 2026 - The latest GeneSight Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatme
Read more
Report
The GeneSight Test Genetic Insights for Non-Psychiatric Medications
While the GeneSight Test is intended to provide helpful information to health care providers prescribing psychotropic medications, some of the genes evaluated on the GeneSight Test play a role in the metabolism or response to a broader range of medication
Read more
Report
Rooting for Mental Health Heroes at the 2026 Winter Olympics
The Winter Olympics has brought us unforgettable moments-Miracle on Ice, Torvill and Dean's Bolero, the Jamaican bobsled team. They also showed heartbreak: crashes on ski runs, falls on the ice, and injuries that played out in front of millions. These hig
Read more
Report
PRIME Care Time-to-Event Analysis
In 2022, the United States Department of Veterans Affairs (VA) undertook the Precision Medicine in Mental Health Care, or PRIME Care study, the largest pharmacogenomic randomized controlled trial in mental health. They enrolled nearly 2000 veterans with d
Read more
Report
The GeneSight Test: Announces New Updates
As part of our ongoing commitment to ensuring that our tests evolve with the latest scientific research and clinical needs, we've updated the GeneSight Test. The enhancements are designed to give clinicians clearer, more comprehensive genetic insights whe
Read more
Report
Is "Anxiety" on Your Playlist?
"Anxiety, keep on tryin' me I feel it quietly, tryna silence me, yeah Anxiety, shake it off of me Somebody's watchin' me, it's my anxiety, yeah (Brrah) …And it's like I get this tightness in my chest Like an elephant is standing on me And I just let it ta
Read more
Report
Break the resolution cycle: How simple solutions can transform 2026
Like every year, many of us make New Year's resolutions and try to stick to them, but broad, all-or-nothing changes often set us up for failure and can make mental health struggles even worse. Dr. Robin Miller, an integrative medicine physician and founde
Read more
Report
New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner
The post New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner appeared first on GeneSight.
Read more
Report
GeneSight test-guided treatment leads to faster remission and response in patients with depression
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that treatment informed by the GeneSight test led to faster in
Read more
Report
New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner
Faster initial remission and response, persistent benefit over six months SALT LAKE CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc
Read more
Report
Show more news